Plain-English translation of NCT06542653 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is studying whether opening a completely blocked coronary artery using a catheter procedure (called PCI) helps patients live better and longer compared to managing the blockage with medication alone. Researchers are following patients who received one of these two treatments between 2011 and 2017 to see which approach leads to better health outcomes, including fewer heart attacks, strokes, and deaths.
Some patients have coronary arteries that are completely blocked—a condition that can cause chest pain, shortness of breath, or lead to heart attacks. Doctors aren't sure whether opening these blocked arteries with a catheter procedure helps more than using medications to manage the condition, so this trial is comparing the two approaches.
You likely qualify if…
You likely don't qualify if…
Participants in this trial were enrolled based on how their blocked coronary artery was treated: some received a catheter procedure to open the blockage, while others received medication therapy to manage it. The researchers then followed both groups over time, tracking major health events such as heart attacks, strokes, deaths, and the need for additional procedures to assess which approach led to better outcomes.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
China
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Enrollment target
~258 participants
Started
September 2023
Primary completion
September 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 75 Years
Last updated on clinicaltrials.gov in December 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Mei Wang
The First Affiliated Hospital with Nanjing Medical University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.